Submit a manuscript Sign up for article alerts Contact us Support

About Radiation Oncology

This page includes information about the aims and scope of Radiation Oncology, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.

The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. Advances in treatment technology, as well as improved understanding of the underlying biological resistance mechanisms, will further strengthen the role of radiation oncology.

Open access

All articles published by Radiation Oncology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Radiation Oncology are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Radiation Oncology therefore levies an article-processing charge of £1170/$1960/€1410 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.

Indexing services

All articles published in Radiation Oncology are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Radiation Oncology include:

  • CAS
  • Cases Database
  • Citebase
  • Current contents
  • DOAJ
  • Embase
  • Google Scholar
  • Index Copernicus
  • MEDLINE
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • SCImago
  • Scirus
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

All case reports published in this journal will also be indexed in Cases Database.

Radiation Oncology is tracked by Thomson Reuters (ISI) and has an Impact Factor of 2.11.

Publication and peer review process

Criteria for publication

 

Research: reports of data from original research.

Reviews: comprehensive, authoritative, descriptions of any subject within the scope of the journal. Although usually invited, if you are interested in submitting a review, please send an outline of your proposed review to the Radiation Oncology Editorial Team.

Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. All case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians.

Commentaries: short, focused and opinionated articles on any subject within the scope of the journal. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion leaders.

Methodology articles: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method.

Short reports: brief reports of data from original research.

Study protocol: describe proposed or ongoing research, providing a detailed account of the hypothesis, rationale, and methodology of the study.

Peer-review policies

An appropriate Section Editor or the Editor-in-Chief initially evaluates the suitability of manuscripts submitted to Radiation Oncology. Those manuscripts deemed suitable will be assigned 3 peer reviewers. Once two concordant reviews are received, the Editor-in-Chief will make a decision. In problematic cases an expert Editorial Board member will reach a decision together with the Editor-in-Chief.

Edited by Claus Belka, Radiation Oncology is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Radiation Oncology, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Radiation Oncology will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Radiation Oncology should adhere to BioMed Central's editorial policies.

Citing articles in Radiation Oncology

Articles in Radiation Oncology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Radiat Oncol [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Radiat Oncol 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Radiation Oncology?

High visibility

Radiation Oncology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Radiation Oncology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Radiation Oncology, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Radiation Oncology gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Radiation Oncology are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Radiation Oncology's pages and on the BioMed Central homepage.

In addition, articles published in Radiation Oncology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Radiation Oncology. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Radiation Oncology retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.